Companies: 10,795·Total market cap: $144.5T
CorMedix Inc.

CorMedix Inc.

CRMDNASDAQHealthcare● Active
$8.54
+$0.18(+2.15%)
Market Cap$669979149
P/E Ratio—
52W High$17.43
52W Low$6.13
Overview

CorMedix Inc. (CRMD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001410098 · CRMD · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,000+
Total Filings
8-K
Latest Form
2026-06-08
Most Recent
2010
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001410098 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-05
Fiscal Year End
Mar 5, 2026
Accession No.
0001213900-26-023889
Primary Document
ea0278169-10k_cormedix.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001410098 · Accession 0001213900-26-023889

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-06-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
CURRENT REPORT
2026-06-08
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-14
View
ARSARS
ARS
2026-04-29
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL MATERIALS
2026-04-29
View
DEF 14AProxy Statement
PROXY STATEMENT
2026-04-29
View
8-KCurrent Report
CURRENT REPORT
2026-04-27
View
PRE 14APRE 14A
PROXY STATEMENT
2026-04-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
8-KCurrent Report
CURRENT REPORT
2026-03-06
View
10-KAnnual Report
ANNUAL REPORT
2026-03-05
View
8-KCurrent Report
CURRENT REPORT
2026-03-05
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-01-15
View
8-KCurrent Report
CURRENT REPORT
2026-01-08
View
Showing 1–15 of 555 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001410098  |  Exchange: NASDAQ · Healthcare

CorMedix Inc. (NASDAQ: CRMD) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001410098, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CorMedix Inc.'s most comprehensive regulatory disclosure. The most recent CorMedix Inc. 10-K was filed on 2026-03-05 for fiscal year ending 2026. Historical CRMD 10-K annual reports are available from 2012 through 2026.

Investors researching CorMedix Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TNGX SEC Filings →NBTX SEC Filings →SEPN SEC Filings →PVLA SEC Filings →BCAX SEC Filings →SVRA SEC Filings →EYPT SEC Filings →ABUS SEC Filings →
→ CRMD Financials→ CRMD Earnings→ CRMD Insider Trades

Frequently Asked Questions

CRMD SEC Filings · 8 questions

CorMedix Inc. (CRMD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. CorMedix Inc.'s CIK is 0001410098.

CRMD SEC filingsCorMedix Inc. SEC documentsfind CRMD 10-K